The North America Yeast Extracts and Beta-Glucan Market is expected to witness market growth of 7.4% CAGR during the forecast period (2022-2028).
However, mushroom beta-glucans have been linked to improved immunological health, the molecular composition of beta-glucans generated from mushrooms is variable and unpredictable, making it difficult to assess their efficacy. The molecular composition of each variety of mushrooms differs and biological actions of different mushroom beta-glucans are modified due to these differences. Lentinan, a compound generated from Lentinus edodes with a & szlig;-1,3-D-glucan backbone and very short beta-1,6 side chains, is the most investigated strain of mushroom beta-glucan.
Beta-glucans derived from yeast may aid in cholesterol reduction. They have been found in studies to reduce total cholesterol as well as LDL cholesterol levels. However, they do not impact to influence HDL, also called good cholesterol or triglycerides. In addition, beta-glucan has been found helpful in patients with certain forms of cancer. More research and development activities are required to determine its efficacy. Beta-glucans can also aid patients with cervical problems as well as head and neck malignancies. These immunological health benefits have been established in a number of populations, including families with healthy agers, children, athletes, and people who lead active lifestyles, as well as those who are under stress from their hectic jobs, such as firemen or medical students.
North America is a key market with significant potential for the use and consumption of beta-glucan in a variety of applications, including functional foods, nutritional drinks, dietary supplements, medicinal uses, and more. The region's growing obese population, as well as their growing health worries, is two significant factors driving them to embrace nutritional medication. According to the Centers for Disease Control and Prevention, United States, Obesity affected 93.3 million adults in the United States in 2015-2016. Consumers need easy access to nutrients and are open to the concept of using food and supplements to treat ailments. The rising popularity of algae-derived goods, as well as consumer knowledge of their benefits, has generated a major market opportunity for food and beverage producers in the region.
The US market dominated the North America Yeast Extracts and Beta-Glucan Market by Country in 2021, and is expected to continue to be a dominant market till 2018; thereby, achieving a market value of $476.1 Million by 2028. The Canada market is experiencing a CAGR of 9.9% during (2022-2028). Additionally, The Mexico market is expected to witness a CAGR of 8.9% during (2022-2028).
Based on Type the market is segmented into Yeast Extract and Yeast Beta-Glucan. Based on Application, the market is segmented into Food & Beverages, Animal Feed, Pharmaceutical, Cosmetic, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Chr. Chr. Hansen holding A/S, Associated British Foods PLC (Wittington Investments Limited), Archer Daniels Midland Company, Alltech, Inc., Thai Foods International Co., Ltd., Nutra Green Biotechnology Co., Ltd., Lesaffre Group, Angel Yeast Co., Ltd., Lallemand, Inc., and Specialty Biotech Co., Ltd.
By Type
By Country
However, mushroom beta-glucans have been linked to improved immunological health, the molecular composition of beta-glucans generated from mushrooms is variable and unpredictable, making it difficult to assess their efficacy. The molecular composition of each variety of mushrooms differs and biological actions of different mushroom beta-glucans are modified due to these differences. Lentinan, a compound generated from Lentinus edodes with a & szlig;-1,3-D-glucan backbone and very short beta-1,6 side chains, is the most investigated strain of mushroom beta-glucan.
Beta-glucans derived from yeast may aid in cholesterol reduction. They have been found in studies to reduce total cholesterol as well as LDL cholesterol levels. However, they do not impact to influence HDL, also called good cholesterol or triglycerides. In addition, beta-glucan has been found helpful in patients with certain forms of cancer. More research and development activities are required to determine its efficacy. Beta-glucans can also aid patients with cervical problems as well as head and neck malignancies. These immunological health benefits have been established in a number of populations, including families with healthy agers, children, athletes, and people who lead active lifestyles, as well as those who are under stress from their hectic jobs, such as firemen or medical students.
North America is a key market with significant potential for the use and consumption of beta-glucan in a variety of applications, including functional foods, nutritional drinks, dietary supplements, medicinal uses, and more. The region's growing obese population, as well as their growing health worries, is two significant factors driving them to embrace nutritional medication. According to the Centers for Disease Control and Prevention, United States, Obesity affected 93.3 million adults in the United States in 2015-2016. Consumers need easy access to nutrients and are open to the concept of using food and supplements to treat ailments. The rising popularity of algae-derived goods, as well as consumer knowledge of their benefits, has generated a major market opportunity for food and beverage producers in the region.
The US market dominated the North America Yeast Extracts and Beta-Glucan Market by Country in 2021, and is expected to continue to be a dominant market till 2018; thereby, achieving a market value of $476.1 Million by 2028. The Canada market is experiencing a CAGR of 9.9% during (2022-2028). Additionally, The Mexico market is expected to witness a CAGR of 8.9% during (2022-2028).
Based on Type the market is segmented into Yeast Extract and Yeast Beta-Glucan. Based on Application, the market is segmented into Food & Beverages, Animal Feed, Pharmaceutical, Cosmetic, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Chr. Chr. Hansen holding A/S, Associated British Foods PLC (Wittington Investments Limited), Archer Daniels Midland Company, Alltech, Inc., Thai Foods International Co., Ltd., Nutra Green Biotechnology Co., Ltd., Lesaffre Group, Angel Yeast Co., Ltd., Lallemand, Inc., and Specialty Biotech Co., Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Yeast Extract
- Yeast Beta-Glucan
- Food & Beverages
- Animal Feed
- Pharmaceutical
- Cosmetic
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Chr. Hansen holding A/S
- Associated British Foods PLC (Wittington Investments Limited)
- Archer Daniels Midland Company
- Alltech, Inc.
- Thai Foods International Co., Ltd.
- Nutra Green Biotechnology Co., Ltd.
- Lesaffre Group
- Angel Yeast Co., Ltd.
- Lallemand, Inc.
- Specialty Biotech Co., Ltd.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. North America Yeast Extracts and Beta-Glucan Market by Type
Chapter 5. North America Yeast Extracts and Beta-Glucan Market by Application
Chapter 6. North America Yeast Extracts and Beta-Glucan Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Chr. Hansen holding A/S
- Associated British Foods PLC (Wittington Investments Limited)
- Archer Daniels Midland Company
- Alltech, Inc.
- Thai Foods International Co., Ltd.
- Nutra Green Biotechnology Co., Ltd.
- Lesaffre Group
- Angel Yeast Co., Ltd.
- Lallemand, Inc.
- Specialty Biotech Co., Ltd.
Methodology
LOADING...
